Cited by 356Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchAmyotrophic Lateral Sclerosis Research

Genetic aspects of Alzheimer disease.

Open access
Bird, Thomas D.·2008·Genetics in Medicine

Abstract

Alzheimer disease is the most common cause of dementia and represents a major public health problem. The neuropathologic findings of amyloid-beta plaques and tau containing neurofibrillary tangles represent important molecular clues to the underlying pathogenesis. Genetic factors are well recognized, but complicated. Three rare forms of autosomal-dominant early-onset familial Alzheimer disease have been identified and are associated with mutations in amyloid precursor protein, presenilin 1, and presenilin 2 genes. The more common late-onset form of Alzheimer disease is assumed to be polygenic/multifactorial. However, thus far the only clearly identified genetic risk factor for Alzheimer disease is Apo lipoprotein E. The epsilon4 allele of Apo lipoprotein E influences age at onset of Alzheimer disease, but is neither necessary nor sufficient for the disease. The search continues for the discovery of additional genetic influences.

Integrity signals

Registry

Crossref · 10.1097/gim.0b013e31816b64dc

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A small subset of Alzheimer's disease cases is caused by autosomal-dominant AD mutations in PSEN1, PSEN2, and APP, leading to early-onset AD with amyloid plaques and neurofibrillary tangles.

    “While most cases are sporadic (SAD), a small subset is caused by autosomal-dominant AD (ADAD) mutations in presenilin 1 (PSEN1), presenilin 2 (PSEN2), and amyloid precursor protein (APP), leading to early-onset AD with hallmark amyloid plaques and neurofibrillary tangles (Bateman et al., 2011; Bird, 2008; Selkoe and Hardy, 2016).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Bird, T. D.
Affiliations
University of Washington (US)
Corresponding author
Bird, Thomas D.
Venue
Genetics in Medicine
Publisher
Elsevier BV
Published
2008-04
Volume
10
Issue
4
Pages
231-239
ISSN
1098-3600 (ISSN-L)
OpenAlex
W2060480788
Cited by
356
References
2
Citations by year
2026: 9 · 2025: 17 · 2024: 16 · 2023: 14 · 2022: 19 · 2021: 24 · 2020: 20 · 2019: 20 · 2018: 10 · 2017: 24 · 2016: 16 · 2015: 16 · 2014: 18 · 2013: 14 · 2012: 15
FWCI
3.75
Type
journal article
Language
en
Open access
Locations
  • Genetics in Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institute on Aging (P50AG005136)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
Keywords
Alzheimer's disease, genetic risk factors, amyloid plaques, neurofibrillary tangles, amyloid precursor protein mutations, presenilin 1, presenilin 2, late-onset Alzheimer's disease, polygenic inheritance, apolipoprotein E, APOE ε4, dementia
MeSH terms
Alzheimer Disease, Diagnosis, Differential, Genetic Counseling, Genetic Testing, Humans

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review